Enzalutamide in Patients With High-risk Prostate Cancer

Clinical trial NCT01927627 · COMPLETED

Trial details

NCT number: NCT01927627
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate

Start date: 2013-11-11
Primary completion: 2017-03-29
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.